Early antipsychotic treatment phases commonly involve neurological, metabolic, and cardiovascular complications appearing within days or weeks. Key risks include extrapyramidal symptoms like acute dystonia or akathisia, rapid weight gain, and rare but severe conditions such as neuroleptic malignant syndrome or drug-induced parkinsonism.
- Neurological symptoms: Acute dystonia causes painful muscle contractions within 5 days of starting medication.
- Restlessness (Akathisia): Patients often experience intense inner restlessness and constant pacing within 1–2 weeks.
- Metabolic changes: Significant insulin resistance and lipid increases can manifest within only 2 weeks.
- Cardiac risks: Potential QT interval prolongation and orthostatic hypotension may cause dizziness or fainting.
Bookimed Expert Insight: While many focus on long-term weight gain, our data shows metabolic shifts often start by day 3. In Bangkok, specialists like Dr. Pichayut Kasemphakdeephong at Day One Rehabilitation Center emphasize early bloodwork. Requesting labs at the 2-week mark instead of waiting 3 months catch these shifts early.
Patient Consensus: Many describe early treatment as feeling like a zombie or having ants under their skin. They recommend tracking daily sleep and mood in a journal to distinguish side effects from the condition.